PEN - Penumbra, Inc.
NYSE
->
Healthcare
->
Medical Devices
Alameda,
United States
Type: Equity
PEN price evolution
PEN
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $167.49 | $100.76 | $114.17 | $94.69 |
| Short term investments | $121.7 | $148.1 | $106.9 | $104.41 |
| Net receivables | $201.77 | $206.62 | $208.97 | $207.36 |
| Inventory | $388.02 | $374.25 | $358.77 | $344.04 |
| Total current assets | $915.4 | $868.48 | $827.88 | $786.49 |
| Long term investments | ||||
| Property, plant & equipment | $292.54 | $281.52 | $285.2 | $287.63 |
| Goodwill & intangible assets | $237.33 | $239.41 | $242.28 | $244.83 |
| Total noncurrent assets | $640.9 | $599.9 | $604.66 | $608.81 |
| Total investments | $121.7 | $148.1 | $106.9 | $104.41 |
| Total assets | $1556.31 | $1468.38 | $1432.53 | $1395.3 |
| Current liabilities | ||||
| Accounts payable | $27.16 | $28 | $25.82 | $28.2 |
| Deferred revenue | ||||
| Short long term debt | $13.43 | $12.9 | $12.7 | $12.26 |
| Total current liabilities | $151.14 | $145.08 | $144.12 | $146.33 |
| Long term debt | $220.91 | $215.9 | $218.58 | $221.26 |
| Total noncurrent liabilities | $226.22 | $219.16 | $221.87 | $224.5 |
| Total debt | $234.34 | $228.79 | $231.28 | $233.52 |
| Total liabilities | $377.36 | $364.24 | $365.99 | $370.83 |
| Shareholders' equity | ||||
| Retained earnings | $134.86 | $80.64 | $71.43 | $52.47 |
| Other shareholder equity | -$3.15 | -$7.24 | -$5.58 | -$6.86 |
| Total shareholder equity | $1178.94 | $1104.14 | $1066.54 | $1024.47 |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $167.49 | $69.86 | $59.38 | $69.67 |
| Short term investments | $121.7 | $118.17 | $195.5 | $195.16 |
| Net receivables | $201.77 | $203.38 | $133.94 | $114.61 |
| Inventory | $388.02 | $334.01 | $263.5 | $219.53 |
| Total current assets | $915.4 | $755.7 | $681.47 | $617.7 |
| Long term investments | ||||
| Property, plant & equipment | $292.54 | $290.97 | $227.09 | $127.43 |
| Goodwill & intangible assets | $237.33 | $247.21 | $257.01 | $19.01 |
| Total noncurrent assets | $640.9 | $615.19 | $562.78 | $205.28 |
| Total investments | $121.7 | $118.17 | $195.5 | $195.16 |
| Total assets | $1556.31 | $1370.89 | $1244.25 | $822.98 |
| Current liabilities | ||||
| Accounts payable | $27.16 | $26.68 | $13.42 | $14.11 |
| Deferred revenue | ||||
| Short long term debt | $13.43 | $11.95 | $9.98 | $6.03 |
| Total current liabilities | $151.14 | $144.93 | $123.2 | $105.93 |
| Long term debt | $220.91 | $24.86 | $163.57 | $71.25 |
| Total noncurrent liabilities | $226.22 | $227.1 | $167.13 | $79.26 |
| Total debt | $234.34 | $235.77 | $173.55 | $77.28 |
| Total liabilities | $377.36 | $372.03 | $290.32 | $185.19 |
| Shareholders' equity | ||||
| Retained earnings | $134.86 | $43.9 | $45.91 | $40.62 |
| Other shareholder equity | -$3.15 | -$4.62 | -$2.63 | $2.54 |
| Total shareholder equity | $1178.94 | $998.86 | $953.93 | $641.5 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $284.68 | $270.95 | $261.5 | $241.4 |
| Cost of revenue | $97.69 | $93.23 | $94.64 | $90.33 |
| Gross Profit | $186.99 | $177.72 | $166.86 | $151.07 |
| Operating activities | ||||
| Research & development | $21.94 | $20.96 | $21.54 | $19.99 |
| Selling, general & administrative | $130.02 | $125.92 | $127.44 | $123.08 |
| Total operating expenses | $151.96 | $165.09 | $148.97 | $143.06 |
| Operating income | $35.03 | $12.63 | $17.89 | $8.01 |
| Income from continuing operations | ||||
| EBIT | $38.16 | $13.3 | $19.54 | $8.65 |
| Income tax expense | -$16.06 | $4.09 | $0.58 | $0.09 |
| Interest expense | ||||
| Net income | ||||
| Net income | $54.22 | $9.21 | $18.96 | $8.56 |
| Income (for common shares) | $54.22 | $9.21 | $18.96 | $8.56 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $1058.52 | $847.13 | $747.59 | $560.41 |
| Cost of revenue | $375.88 | $311.93 | $272.21 | $222.24 |
| Gross Profit | $682.64 | $535.21 | $475.38 | $338.18 |
| Operating activities | ||||
| Research & development | $84.42 | $79.41 | $104.55 | $90.05 |
| Selling, general & administrative | $506.45 | $449.72 | $378.33 | $287.07 |
| Total operating expenses | $609.09 | $529.13 | $482.88 | $377.12 |
| Operating income | $73.55 | $6.08 | -$7.5 | -$38.94 |
| Income from continuing operations | ||||
| EBIT | $79.65 | $3.89 | -$7.84 | -$34.46 |
| Income tax expense | -$11.3 | $5.89 | -$13.13 | -$18.76 |
| Interest expense | ||||
| Net income | ||||
| Net income | $90.95 | -$2 | $5.28 | -$15.7 |
| Income (for common shares) | $90.95 | -$2 | $5.28 | -$15.7 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Net income | $54.22 | $9.21 | $18.96 | $8.56 |
| Operating activities | ||||
| Depreciation | $7.04 | $6.93 | $6.71 | $6.58 |
| Business acquisitions & disposals | -$0.99 | |||
| Stock-based compensation | $10.79 | $14.14 | $12.82 | $12.77 |
| Total cash flows from operations | $36.26 | $30.84 | $17.1 | $13.13 |
| Investing activities | ||||
| Capital expenditures | -$3.65 | -$3.33 | -$4.34 | -$3.89 |
| Investments | $27.93 | -$40.08 | -$1.83 | $14.61 |
| Total cash flows from investing | $24.28 | -$44.4 | -$6.67 | $10.71 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $7.37 | $0.83 | $10 | $2.21 |
| Net borrowings | -$0.53 | -$0.5 | -$0.48 | -$0.47 |
| Total cash flows from financing | $5.92 | $0.21 | $8.69 | $1.38 |
| Effect of exchange rate | $0.27 | -$0.07 | $0.36 | -$0.39 |
| Change in cash and equivalents | $66.73 | -$13.41 | $19.48 | $24.83 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $90.95 | -$2 | $5.28 | -$15.7 |
| Operating activities | ||||
| Depreciation | $27.26 | $24.32 | $16.41 | $12.89 |
| Business acquisitions & disposals | -$0.99 | $2.92 | ||
| Stock-based compensation | $50.52 | $37.38 | $65.76 | $25.54 |
| Total cash flows from operations | $97.33 | -$55.66 | $9.5 | -$33.24 |
| Investing activities | ||||
| Capital expenditures | -$15.21 | -$19.3 | -$21.18 | -$24.76 |
| Investments | $0.63 | $74.09 | -$3.07 | -$76.33 |
| Total cash flows from investing | -$16.08 | $54.79 | -$21.73 | -$104.15 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $20.41 | $21.55 | $18.37 | $151.3 |
| Net borrowings | -$1.98 | -$1.75 | -$1.45 | -$3.42 |
| Total cash flows from financing | $16.2 | $11.62 | $0.84 | $134.92 |
| Effect of exchange rate | $0.17 | -$0.27 | $1.11 | -$0.64 |
| Change in cash and equivalents | $97.63 | $10.48 | -$10.29 | -$3.11 |
News
Fundamentals
| Market cap | $7.96B |
|---|---|
| Enterprise value | $8.02B |
| Shares outstanding | 38.68M |
| Revenue | $1.06B |
|---|---|
| EBITDA | $106.91M |
| EBIT | $79.65M |
| Net Income | $90.95M |
| Revenue Q/Q | 28.69% |
| Revenue Y/Y | 24.95% |
| P/E ratio | 87.48 |
|---|---|
| EV/Sales | 7.58 |
| EV/EBITDA | 75.05 |
| EV/EBIT | 100.74 |
| P/S ratio | 7.52 |
| P/B ratio | 6.73 |
| Book/Share | 30.56 |
| Cash/Share | 4.33 |
| EPS | $2.35 |
|---|---|
| ROA | 6.22% |
| ROE | 8.32% |
| Debt/Equity | 0.32 |
|---|---|
| Net debt/EBITDA | 1.96 |
| Current ratio | 6.06 |
| Quick ratio | 3.49 |